Advertisement
Journal of Hepatology
EASL
Advanced searchSave search
Corrigendum| Volume 77, ISSUE 1, P271, July 2022

Corrigendum to ‘Baveno VII – Renewing consensus in portal hypertension’ [J Hepatol (2022) 959-974]

Published:April 14, 2022DOI:https://doi.org/10.1016/j.jhep.2022.03.024
Corrigendum to ‘Baveno VII – Renewing consensus in portal hypertension’ [J Hepatol (2022) 959-974]
Previous ArticleCorrigendum to ‘Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model’ [J Hepatol (2021) 1420-1433]

      Linked Article

      • Baveno VII – Renewing consensus in portal hypertension
        Journal of HepatologyVol. 76Issue 4
        • Preview
          To expand on the work of previous meetings, a virtual Baveno VII workshop was organised for October 2021. Among patients with compensated cirrhosis or compensated advanced chronic liver disease (cACLD – defined at the Baveno VI conference), the presence or absence of clinically significant portal hypertension (CSPH) is associated with differing outcomes, including risk of death, and different diagnostic and therapeutic needs. Accordingly, the Baveno VII workshop was entitled “Personalized Care for Portal Hypertension”.
        • Full-Text
        • PDF
      It has come to our attention that on page 974 in the Baveno VII Faculty section, one of the faculty member’s names was misspelled “Guogong Han (Xi’an, China)”. The correct spelling is “Guohong Han (Xi’an, China)”. We apologise for any inconvenience caused.

      Article info

      Publication history

      Published online: April 14, 2022

      Identification

      DOI: https://doi.org/10.1016/j.jhep.2022.03.024

      Copyright

      © 2021 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX